CDTX (Cidara Therapeutics, Inc.) Stock Analysis - SEC Filings

Cidara Therapeutics, Inc. (CDTX) is a publicly traded Healthcare sector company. As of May 21, 2026, CDTX trades at $221.38 with a market cap of $6.96B and a P/E ratio of -8.28. CDTX moved +0.03% today. Year to date, CDTX is +228.02%; over the trailing twelve months it is +731.63%. Its 52-week range spans $10.14 to $221.42. Analyst consensus is buy with an average price target of $221.50. Rallies surfaces CDTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CDTX SEC filings?

Rallies organizes CDTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CDTX Key Metrics

Key financial metrics for CDTX
MetricValue
Price$221.38
Market Cap$6.96B
P/E Ratio-8.28
EPS$-26.75
Dividend Yield0.00%
52-Week High$221.42
52-Week Low$10.14
Volume2.69M
Avg Volume0
Revenue (TTM)$1.27M
Net Income$-169.83M
Gross Margin0.00%

Recent CDTX Insider Trades

  • Ward Shane sold 9.96K (~$2.19M) on Dec 10, 2025.
  • Davarpanah Nicole Negar sold 474 (~$29.80K) on Sep 11, 2025.
  • RA CAPITAL MANAGEMENT, L.P. bought 2.27M (~$100.00M) on Jun 26, 2025.

CDTX Analyst Consensus

11 analysts cover CDTX: 1 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $221.50.

Common questions about CDTX

Where can I find CDTX SEC filings?
Rallies organizes CDTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CDTX 10-K and 10-Q filings?
Rallies organizes CDTX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CDTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CDTX. It does not provide personalized investment advice.
CDTX

CDTX